Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA

Autor: Mahmoud Elsabahy, Heba A. Fathi, Hadeel Elzeny, Mohamed A El-Mokhtar, Richen Li, Shiyi Zhang, Karen L. Wooley, Esraa N Ali, Mostafa A. Hamad, Fuwu Zhang
Rok vydání: 2017
Předmět:
Niacinamide
Paclitaxel
Biocompatibility
Cell Survival
Polymers
Pharmaceutical Science
Nanoparticle
Antineoplastic Agents
02 engineering and technology
010402 general chemistry
01 natural sciences
Chitosan
Mice
Structure-Activity Relationship
chemistry.chemical_compound
Drug Delivery Systems
Organophosphorus Compounds
In vivo
Cell Line
Tumor

Drug Discovery
Animals
Humans
RNA
Small Interfering

Original Research
Pharmacology
chemistry.chemical_classification
Polyethylenimine
Drug Design
Development and Therapy

Dose-Response Relationship
Drug

Molecular Structure
biodegradable nanoparticles
Phenylurea Compounds
Cationic polymerization
Polymer
Sorafenib
021001 nanoscience & nanotechnology
Combinatorial chemistry
polyethylenimine
0104 chemical sciences
Survival Rate
chemistry
siRNA
Injections
Intravenous

polyphosphoester
Nanoparticles
Drug Screening Assays
Antitumor

chitosan
Nanocarriers
0210 nano-technology
Zdroj: Drug Design, Development and Therapy
ISSN: 1177-8881
DOI: 10.2147/dddt.s128503
Popis: Hadeel Elzeny,1,* Fuwu Zhang,2,* Esraa N Ali,1 Heba A Fathi,1 Shiyi Zhang,3 Richen Li,2 Mohamed A El-Mokhtar,4 Mostafa A Hamad,5 Karen L Wooley,2,6 Mahmoud Elsabahy1,6–8 1Assiut International Center of Nanomedicine, Al-Rajhy Liver Hospital, Assiut University, Assiut, Egypt; 2Departments of Chemistry, Chemical Engineering and Materials Science and Engineering, Texas A&M University, College Station, TX, USA; 3School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 4Department of Microbiology and Immunology, Faculty of Medicine, 5Department of Surgery, Faculty of Medicine, Assiut University, Assiut, Egypt; 6Laboratory for Synthetic-Biologic Interactions, Department of Chemistry, Texas A&M University, College Station, TX, USA; 7Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, 8Misr University for Science and Technology, 6th of October City, Egypt *These authors contributed equally to this work Abstract: Delivery of multiple therapeutics and/or diagnostic agents to diseased tissues is challenging and necessitates the development of multifunctional platforms. Among the various strategies for design of multifunctional nanocarriers, biodegradable polyphosphoester (PPE) polymers have been recently synthesized via a rapid and simple synthetic strategy. In addition, the chemical structure of the polymer could be tuned to form nanoparticles with varying surface chemistries and charges, which have shown exceptional safety and biocompatibility as compared to several commercial agents. The purpose of this study was to exploit a mixture of PPE nanoparticles of cationic and neutral surface charges for multiple delivery of anticancer drugs (ie, sorafenib and paclitaxel) and nucleic acids (ie, siRNA). Cationic PPE polymers could efficiently complex siRNA, and the stability of the nanoparticles could be maintained in physiological solutions and upon freeze-drying and were able to deliver siRNA in vivo when injected intravenously in mice. Commercially available cationic polyethylenimine polymer had LD50 of ca. 61.7 mg/kg in mice, whereas no animal died after injection of the cationic PPE polymer at a dose of >130 mg/kg. Neutral PPE nanoparticles were able to encapsulate two hydrophobic drugs, namely, sorafenib and paclitaxel, which are commonly used for the treatment of hepatocellular carcinoma. Mixing the neutral and cationic PPE nanoparticles did not result in any precipitation, and the size characteristics of both types of nanoparticles were maintained. Hence, PPE polymers might have potential for the delivery of multiple drugs and diagnostic agents to diseased tissues via simple synthesis of the individual polymers and assembly into nanoparticles that can host several drugs while being mixed in the same administration set, which is of importance for industrial and clinical development. Keywords: biodegradable nanoparticles, polyphosphoester, chitosan, polyethylenimine, siRNA, sorafenib, paclitaxel
Databáze: OpenAIRE